Business Update29 Jun 2025, 05:00 pm
Aurobindo Pharma's Kakinada Facility Restarts Penicillin-G Production After APPCB Consent
AI Summary
Aurobindo Pharma Ltd. has announced the restart of Penicillin-G production at its Kakinada facility following the receipt of a 'Consent to Operate' from the Andhra Pradesh Pollution Control Board. The production has resumed with immediate effect after the approval from APPCB. This development comes after the company's intimation letters dated April 28, 2025, and May 26, 2025, where they were awaiting the renewal of the CTO.
Key Highlights
- Aurobindo Pharma's Kakinada facility restarts Penicillin-G production
- Restart follows the receipt of Consent to Operate from Andhra Pradesh Pollution Control Board
- Production resumes immediately after approval
- Announcement comes after the company's intimation letters dated April 28, 2025, and May 26, 2025